Looking Statements Except News Today

Sonoma Pharmaceuticals Reports Recent Publication from Australia Highlighting ...

Rekor Systems Announces Closing of Follow-On Public Offering of Common ...

Sonoma Pharmaceuticals Introduces Lumacyn Clarifying Mist, an All Natural, ...

Accenture to Expand Government Transformation Capabilities in the U.K. with Acquisition of 6point6 LONDON; Oct. 31, 2023 - Accenture has signed an agreement to...

Accenture Acquires Creative Change Management Consultancy, The Storytellers LONDON; Oct.13, 2023 - Accenture has acquired The Storytellers, a U.K. creative...

Repositioning Lumen for Stabilization and Growth JUNE 5, 2023 Forward-Looking Statements Except for historical and factual information, the... | June 5, 2023

/PRNewswire/ -- One year after Lumen Technologies (NYSE: LUMN) established a new subsea fiber route between the U.S. and France, the company is again...

Grace Hopper subsea cable ups capacity, connects Lumen landing stations in the U.S. and U.K. DENVER, Sept. 21, 2022 /PRNewswire/ -- One year after Lumen Technologies (NYSE: LUMN) established

NOVATO, Calif., May 09, 2022 (GLOBE NEWSWIRE) -- Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE), a biopharmaceutical company focused on the development and commercialization of novel products for rare and ultra-rare diseases,

- Toripalimab plus chemotherapy demonstrates improvement in co-primary endpoints of PFS and OS in patients with advanced ESCC -